SCHEMBL27708992

SCHEMBL27708992

[MgH2].[c]1ccccc1CN1CCOCC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 1/20 0.51
CYP2A13 Q16696 6/20 0.47
CXCR4 P61073 1/20 0.46
HTT P42858 1/20 0.45
HRH3 Q9Y5N1 1/20 0.44
MAPT P10636 2/20 0.44
POLB P06746 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CYP2C9 P11712 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NCF1 P14598 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159991 0.98 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1CYP2A13CXCR4
SCHEMBL27801843 0.92 CYP2A13 (0.47) ALDH1A1KMT2AMEN1CYP2A13CXCR4
SCHEMBL1741859 0.83 SIGMAR1 (0.56) ALDH1A1KMT2AMEN1HTTMAPT
SCHEMBL5380547 0.82 ALDH1A1 (0.39) ALDH1A1HRH3SIGMAR1CYP2D6CYP2C19
SCHEMBL844945 0.82 HRH3 (0.43) ALDH1A1HTTHRH3MAPTSIGMAR1
SCHEMBL844842 0.80 HRH3 (0.47) ALDH1A1HTTHRH3POLBSIGMAR1
SCHEMBL16720461 0.78 DRD4 (0.59) ALDH1A1HTTSIGMAR1CYP2D6KDM4E
SCHEMBL1449845 0.77 MC4R (0.55) ALDH1A1POLBSIGMAR1KDM4E
SCHEMBL759018 0.77 SIGMAR1 (0.55) ALDH1A1KMT2AMEN1CXCR4HRH3
SCHEMBL7388610 0.76 CYP3A4 (0.54) ALDH1A1KMT2AMEN1CYP2A13HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101228180-B Tripeptides as hepatitis C virus inhibitors BRISTOL MYERS SQUIBB CO 2011-03-09 CN disclosed
CN-101228180-A Tripeptides as hepatitis C virus inhibitors BRISTOL MYERS SQUIBB CO (US) 2008-07-23 CN disclosed